Next听generation听sequencing听(NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various听sequencing听reactions occur at the same time, bringing about vast amounts of听sequencing听data for a little division of the cost of Sanger听sequencing.
The global Next-Generation Sequencing Data Analysis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Next-Generation Sequencing Data Analysis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next-Generation Sequencing Data Analysis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next-Generation Sequencing Data Analysis in Academic Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next-Generation Sequencing Data Analysis include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PierianDx, Intrexon Bioinformatics Germany GmbH and Partek, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Sequencing Data Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Sequencing Data Analysis.
Report Scope
The Next-Generation Sequencing Data Analysis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Sequencing Data Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Sequencing Data Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
PierianDx
Intrexon Bioinformatics Germany GmbH
Partek, Inc.
Eurofins Scientific
Pacific Biosciences of California, Inc.
DNASTAR, Inc.
Congenica Ltd.
Fabric Genomics, Inc.
Genuity Science
DNAnexus Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene
Segment by Type
In-house
Outsourced
Segment by Application
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Other Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing Data Analysis companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Next-Generation Sequencing Data Analysis 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In-house
1.2.3 Outsourced
1.3 麻豆原创 by Application
1.3.1 Global Next-Generation Sequencing Data Analysis 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research
1.3.3 Clinical Research
1.3.4 Hospitals & Clinics
1.3.5 Pharma & Biotech Entities
1.3.6 Other Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Sequencing Data Analysis 麻豆原创 Perspective (2019-2030)
2.2 Next-Generation Sequencing Data Analysis Growth Trends by Region
2.2.1 Global Next-Generation Sequencing Data Analysis 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next-Generation Sequencing Data Analysis Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Next-Generation Sequencing Data Analysis Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Next-Generation Sequencing Data Analysis 麻豆原创 Dynamics
2.3.1 Next-Generation Sequencing Data Analysis Industry Trends
2.3.2 Next-Generation Sequencing Data Analysis 麻豆原创 Drivers
2.3.3 Next-Generation Sequencing Data Analysis 麻豆原创 Challenges
2.3.4 Next-Generation Sequencing Data Analysis 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Sequencing Data Analysis Players by Revenue
3.1.1 Global Top Next-Generation Sequencing Data Analysis Players by Revenue (2019-2024)
3.1.2 Global Next-Generation Sequencing Data Analysis Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Next-Generation Sequencing Data Analysis 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Sequencing Data Analysis Revenue
3.4 Global Next-Generation Sequencing Data Analysis 麻豆原创 Concentration Ratio
3.4.1 Global Next-Generation Sequencing Data Analysis 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Sequencing Data Analysis Revenue in 2023
3.5 Next-Generation Sequencing Data Analysis Key Players Head office and Area Served
3.6 Key Players Next-Generation Sequencing Data Analysis Product Solution and Service
3.7 Date of Enter into Next-Generation Sequencing Data Analysis 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Sequencing Data Analysis Breakdown Data by Type
4.1 Global Next-Generation Sequencing Data Analysis Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Next-Generation Sequencing Data Analysis Forecasted 麻豆原创 Size by Type (2025-2030)
5 Next-Generation Sequencing Data Analysis Breakdown Data by Application
5.1 Global Next-Generation Sequencing Data Analysis Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Next-Generation Sequencing Data Analysis Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Next-Generation Sequencing Data Analysis 麻豆原创 Size (2019-2030)
6.2 North America Next-Generation Sequencing Data Analysis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2019-2024)
6.4 North America Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Sequencing Data Analysis 麻豆原创 Size (2019-2030)
7.2 Europe Next-Generation Sequencing Data Analysis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2019-2024)
7.4 Europe Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing Data Analysis 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Next-Generation Sequencing Data Analysis 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next-Generation Sequencing Data Analysis 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Next-Generation Sequencing Data Analysis 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Sequencing Data Analysis 麻豆原创 Size (2019-2030)
9.2 Latin America Next-Generation Sequencing Data Analysis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing Data Analysis 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Next-Generation Sequencing Data Analysis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Next-Generation Sequencing Data Analysis 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. Next-Generation Sequencing Data Analysis Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Next-Generation Sequencing Data Analysis Introduction
11.2.4 QIAGEN Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Detail
11.3.2 Illumina, Inc. Business Overview
11.3.3 Illumina, Inc. Next-Generation Sequencing Data Analysis Introduction
11.3.4 Illumina, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.3.5 Illumina, Inc. Recent Development
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Detail
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Sequencing Data Analysis Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Development
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Detail
11.5.2 Agilent Technologies, Inc. Business Overview
11.5.3 Agilent Technologies, Inc. Next-Generation Sequencing Data Analysis Introduction
11.5.4 Agilent Technologies, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.5.5 Agilent Technologies, Inc. Recent Development
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Detail
11.6.2 Bio-Rad Laboratories, Inc. Business Overview
11.6.3 Bio-Rad Laboratories, Inc. Next-Generation Sequencing Data Analysis Introduction
11.6.4 Bio-Rad Laboratories, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.6.5 Bio-Rad Laboratories, Inc. Recent Development
11.7 PierianDx
11.7.1 PierianDx Company Detail
11.7.2 PierianDx Business Overview
11.7.3 PierianDx Next-Generation Sequencing Data Analysis Introduction
11.7.4 PierianDx Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.7.5 PierianDx Recent Development
11.8 Intrexon Bioinformatics Germany GmbH
11.8.1 Intrexon Bioinformatics Germany GmbH Company Detail
11.8.2 Intrexon Bioinformatics Germany GmbH Business Overview
11.8.3 Intrexon Bioinformatics Germany GmbH Next-Generation Sequencing Data Analysis Introduction
11.8.4 Intrexon Bioinformatics Germany GmbH Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.8.5 Intrexon Bioinformatics Germany GmbH Recent Development
11.9 Partek, Inc.
11.9.1 Partek, Inc. Company Detail
11.9.2 Partek, Inc. Business Overview
11.9.3 Partek, Inc. Next-Generation Sequencing Data Analysis Introduction
11.9.4 Partek, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.9.5 Partek, Inc. Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Next-Generation Sequencing Data Analysis Introduction
11.10.4 Eurofins Scientific Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.10.5 Eurofins Scientific Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Detail
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Next-Generation Sequencing Data Analysis Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 DNASTAR, Inc.
11.12.1 DNASTAR, Inc. Company Detail
11.12.2 DNASTAR, Inc. Business Overview
11.12.3 DNASTAR, Inc. Next-Generation Sequencing Data Analysis Introduction
11.12.4 DNASTAR, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.12.5 DNASTAR, Inc. Recent Development
11.13 Congenica Ltd.
11.13.1 Congenica Ltd. Company Detail
11.13.2 Congenica Ltd. Business Overview
11.13.3 Congenica Ltd. Next-Generation Sequencing Data Analysis Introduction
11.13.4 Congenica Ltd. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.13.5 Congenica Ltd. Recent Development
11.14 Fabric Genomics, Inc.
11.14.1 Fabric Genomics, Inc. Company Detail
11.14.2 Fabric Genomics, Inc. Business Overview
11.14.3 Fabric Genomics, Inc. Next-Generation Sequencing Data Analysis Introduction
11.14.4 Fabric Genomics, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.14.5 Fabric Genomics, Inc. Recent Development
11.15 Genuity Science
11.15.1 Genuity Science Company Detail
11.15.2 Genuity Science Business Overview
11.15.3 Genuity Science Next-Generation Sequencing Data Analysis Introduction
11.15.4 Genuity Science Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.15.5 Genuity Science Recent Development
11.16 DNAnexus Inc.
11.16.1 DNAnexus Inc. Company Detail
11.16.2 DNAnexus Inc. Business Overview
11.16.3 DNAnexus Inc. Next-Generation Sequencing Data Analysis Introduction
11.16.4 DNAnexus Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.16.5 DNAnexus Inc. Recent Development
11.17 SciGenom Labs Pvt. Ltd.
11.17.1 SciGenom Labs Pvt. Ltd. Company Detail
11.17.2 SciGenom Labs Pvt. Ltd. Business Overview
11.17.3 SciGenom Labs Pvt. Ltd. Next-Generation Sequencing Data Analysis Introduction
11.17.4 SciGenom Labs Pvt. Ltd. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.17.5 SciGenom Labs Pvt. Ltd. Recent Development
11.18 Golden Helix, Inc.
11.18.1 Golden Helix, Inc. Company Detail
11.18.2 Golden Helix, Inc. Business Overview
11.18.3 Golden Helix, Inc. Next-Generation Sequencing Data Analysis Introduction
11.18.4 Golden Helix, Inc. Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.18.5 Golden Helix, Inc. Recent Development
11.19 The Beijing Genomics Institute
11.19.1 The Beijing Genomics Institute Company Detail
11.19.2 The Beijing Genomics Institute Business Overview
11.19.3 The Beijing Genomics Institute Next-Generation Sequencing Data Analysis Introduction
11.19.4 The Beijing Genomics Institute Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.19.5 The Beijing Genomics Institute Recent Development
11.20 LifeTech
11.20.1 LifeTech Company Detail
11.20.2 LifeTech Business Overview
11.20.3 LifeTech Next-Generation Sequencing Data Analysis Introduction
11.20.4 LifeTech Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.20.5 LifeTech Recent Development
11.21 Berry Genomics
11.21.1 Berry Genomics Company Detail
11.21.2 Berry Genomics Business Overview
11.21.3 Berry Genomics Next-Generation Sequencing Data Analysis Introduction
11.21.4 Berry Genomics Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.21.5 Berry Genomics Recent Development
11.22 Da An Gene
11.22.1 Da An Gene Company Detail
11.22.2 Da An Gene Business Overview
11.22.3 Da An Gene Next-Generation Sequencing Data Analysis Introduction
11.22.4 Da An Gene Revenue in Next-Generation Sequencing Data Analysis Business (2019-2024)
11.22.5 Da An Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
PierianDx
Intrexon Bioinformatics Germany GmbH
Partek, Inc.
Eurofins Scientific
Pacific Biosciences of California, Inc.
DNASTAR, Inc.
Congenica Ltd.
Fabric Genomics, Inc.
Genuity Science
DNAnexus Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
The Beijing Genomics Institute
LifeTech
Berry Genomics
Da An Gene
听
听
*If Applicable.
